Literature DB >> 10645007

AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen.

V Perissi1, N Menini, E Cottone, D Capello, M Sacco, F Montaldo, M De Bortoli.   

Abstract

Transcription of the ERBB2 oncogene is repressed by oestrogen in human breast cancer cells. We show that a 218 bp fragment of the human ERBB2 gene promoter is responsive to oestrogen in transient transfection in ZR75.1 and SKBR.3 cells when the oestrogen receptor is expressed. Deletion analysis of this fragment shows that a sequence located at the 5' end, which is known to mediate ERBB2 overexpression in breast cancer, is also responsible for the oestrogen response. This sequence binds AP-2 transcription factors and appears functionally identical to an element of the oestrogen-dependent enhancer described in the first intron of human ERBB2. We observed that oestrogen treatment down-regulates expression of AP-2 proteins but does not affect the DNA binding activity of AP-2. Constitutive expression of AP-2beta or AP-2gamma, but not AP-2alpha, abrogates the estrogenic repression. Our results demonstrate that AP-2 transcription factors are implicated in the oestrogenic regulation of ERBB2 gene expression and suggest a complex interplay involving the different AP-2 isoforms and other unidentified factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10645007     DOI: 10.1038/sj.onc.1203303

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription.

Authors:  Si Kee Tan; Zhen Hua Lin; Cheng Wei Chang; Vipin Varang; Kern Rei Chng; You Fu Pan; Eu Leong Yong; Wing Kin Sung; Win King Sung; Edwin Cheung
Journal:  EMBO J       Date:  2011-05-13       Impact factor: 11.598

2.  Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs.

Authors:  Luigi Cicatiello; Margherita Mutarelli; Oli M V Grober; Ornella Paris; Lorenzo Ferraro; Maria Ravo; Roberta Tarallo; Shujun Luo; Gary P Schroth; Martin Seifert; Christian Zinser; Maria Luisa Chiusano; Alessandra Traini; Michele De Bortoli; Alessandro Weisz
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

3.  Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Hari K Bhat
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

4.  Effects of in vivo heregulin beta1 treatment in wild-type and ErbB gene-targeted mice depend on receptor levels and pregnancy.

Authors:  S O'Shea; K Johnson; R Clark; M X Sliwkowski; S L Erickson
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

5.  Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells.

Authors:  Mary S Sakla; Nader S Shenouda; Pete J Ansell; Ruth S Macdonald; Dennis B Lubahn
Journal:  Endocrine       Date:  2007-10-02       Impact factor: 3.633

6.  Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.

Authors:  Francesca Orso; Erika Cottone; Mark D Hasleton; J Claire Ibbitt; Piero Sismondi; Helen C Hurst; Michele De Bortoli
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

7.  Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells.

Authors:  Shuanglin Xiang; Zhenhua Sun; Qiongzhi He; Feng Yan; Yijun Wang; Jian Zhang
Journal:  Med Oncol       Date:  2009-05-08       Impact factor: 3.064

8.  Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM.

Authors:  Simeen Malik; Shiming Jiang; Jason P Garee; Eric Verdin; Adrian V Lee; Bert W O'Malley; Mao Zhang; Narasimhaswamy S Belaguli; Steffi Oesterreich
Journal:  Mol Cell Biol       Date:  2009-11-16       Impact factor: 4.272

9.  Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer.

Authors:  Ali Naderi; Michelle Meyer; Dennis H Dowhan
Journal:  Neoplasia       Date:  2012-04       Impact factor: 5.715

10.  Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.

Authors:  Aejaz Sayeed; Gloria Luciani-Torres; Zhenhang Meng; James L Bennington; Dan H Moore; Shanaz H Dairkee
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.